Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03783546Not ApplicableCompleted

Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial

Role: collaborator

NCT05528263Not ApplicableCompleted

Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)

Role: collaborator

NCT02129686Not ApplicableCompleted

A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients

Role: collaborator

NCT02261571Not ApplicableUnknown

Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer

Role: lead

All 4 trials loaded